08/21/2025
3:00 PM | CytomX Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13G | |
08/18/2025
11:15 PM | CytomX Therapeutics (Filer)
| Form EFFECT | |
08/14/2025
5:07 PM | CytomX Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13G | |
08/14/2025
4:30 PM | CytomX Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
08/14/2025
3:15 PM | CytomX Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G/A | |
08/13/2025
7:07 AM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2025
10:22 AM | CytomX Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
07/09/2025
6:53 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/09/2025
6:55 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
06/13/2025
3:16 PM | Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
3:16 PM | CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/13/2025
3:17 PM | CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
3:17 PM | CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
3:18 PM | CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
3:18 PM | CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
3:19 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
3:06 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
8:00 PM | CytomX Therapeutics (Subject)
Longitude Capital Partners V, LLC (Filed by)
| Form SCHEDULE 13G | |
05/20/2025
8:02 PM | CytomX Therapeutics (Subject)
Seven Fleet Partners LP (Filed by)
| Form SCHEDULE 13G | |
05/14/2025
4:14 PM | CytomX Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
05/12/2025
5:25 AM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
5:14 AM | CytomX Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
3:15 PM | CytomX Therapeutics (Filer)
| Form DEF 14A | |
03/20/2025
3:31 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:32 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:32 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:33 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:34 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:06 PM | CytomX Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
10:34 AM | CytomX Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
4:58 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4/A | |
02/06/2025
4:54 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:55 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:55 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:57 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:02 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:26 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
2:03 PM | Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:28 AM | CytomX Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
